Edwards Lifesciences (EW) Tops Q3 EPS by 5c, Offers Q4 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Edwards Lifesciences (EW) PT Raised to $153 at RBC Capital
October 24, 2018 6:59 AM EDTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $153.00 (from $145.00) while maintaining an Outperform rating.
Novarro notes management commentary on 3Q call moderates our 2019 THV growth outlook.
... More